Procalcitonin and Neonatal Sepsis
Author Information
Author(s): López Sastre José B, Pérez Solís David, Roqués Serradilla Vicente, Fernández Colomer Belén, Coto Cotallo Gil D, Krauel Vidal Xavier, Narbona López Eduardo, García del Río Manuel, Sánchez Luna Manuel, Belaustegui Cueto Antonio, Moro Serrano Manuel, Urbón Artero Alfonso, Álvaro Iglesias Emilio, Cotero Lavín Ángel, Martínez Vilalta Eduardo, Jiménez Cobos Bartolomé
Primary Institution: Grupo de Hospitales Castrillo
Hypothesis
Is procalcitonin a reliable marker for diagnosing neonatal sepsis of nosocomial origin?
Conclusion
Procalcitonin is not sufficiently reliable to be the sole marker of sepsis but can be useful as part of a full sepsis evaluation.
Supporting Evidence
- Serum PCT concentrations were significantly higher in confirmed sepsis cases compared to not confirmed cases.
- Optimal PCT thresholds were identified at different time points after the onset of symptoms.
- The study included a diverse group of neonates from multiple hospitals.
Takeaway
Procalcitonin is a test that helps doctors check if newborns have a serious infection, but it shouldn't be the only test they use.
Methodology
A prospective multicenter study involving 100 infants with clinical suspicion of nosocomial sepsis, measuring serum procalcitonin concentrations at different time points.
Potential Biases
Potential bias due to the lack of a standardized gold standard for diagnosing neonatal sepsis.
Limitations
The study's reliance on strict microbiologic criteria may have led to some true infections being missed.
Participant Demographics
100 neonates aged 4 to 28 days, with 57 males and 43 females.
Statistical Information
P-Value
< 0.0001
Confidence Interval
95% CI, 0.675 to 0.892
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website